Skip to main content
. 2022 Jun 15;147:105728. doi: 10.1016/j.compbiomed.2022.105728

Fig. 1.

Fig. 1

The workflow of this study. First, DATASET-1 was used to develop General-GEN to generate novel and reasonable molecules. Afterward, DATASET-2 was used to fine-tune General-GEN to generate potential MproIs. Finally, the generated MproIs (PMproIL 1) needed to be filtered and validated.